Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Nello Mainolfi Biography and Net Worth

CEO of Kymera Therapeutics

Nello started his drug discovery career at the Novartis Institutes for Biomedical Research, leading teams to identify multiple novel potential medicines that have entered clinical development across a series of disease areas. Notably he led the team that discovered and developed the first complement factor B inhibitor now in late clinical development across a range of indications. Before founding Kymera, Mainolfi was an Entrepreneur in Residence at Atlas Venture and had previously led discovery research at cancer metabolism startup Raze Therapeutics. Nello has authored >60 papers and patents and has written reviews in the areas of medicinal chemistry, drug discovery and protein degradation. Nello was trained at Imperial College, University of London and The Scripps Research Institute in California.

What is Nello Mainolfi's net worth?: The estimated net worth of Nello Mainolfi is at least $15.27 million as of August 4th, 2021. Dr. Mainolfi owns 457,868 shares of Kymera Therapeutics stock worth more than $15,269,898 as of April 26th. This net worth estimate does not reflect any other assets that Dr. Mainolfi may own. Additionally, Dr. Mainolfi receives a salary of $975,200.00 as CEO at Kymera Therapeutics. Learn More about Nello Mainolfi's net worth.
How old is Nello Mainolfi?: Dr. Mainolfi is currently 46 years old. There are 4 older executives and no younger executives at Kymera Therapeutics. Learn More on Nello Mainolfi's age.
What is Nello Mainolfi's salary?: As the CEO of Kymera Therapeutics, Inc., Dr. Mainolfi earns $975,200.00 per year. Learn More on Nello Mainolfi's salary.
How do I contact Nello Mainolfi?: The corporate mailing address for Dr. Mainolfi and other Kymera Therapeutics executives is 200 Arsenal Yards Blvd. Suite 230, Watertown MA, 02472. Kymera Therapeutics can also be reached via phone at 857-285-5300 and via email at [email protected]. Learn More on Nello Mainolfi's contact information.
Has Nello Mainolfi been buying or selling shares of Kymera Therapeutics?: Nello Mainolfi has not been actively trading shares of Kymera Therapeutics during the last ninety days. Most recently, Nello Mainolfi sold 8,612 shares of the business's stock in a transaction on Wednesday, January 12th. The shares were sold at an average price of $52.08, for a transaction totalling $448,512.96. Learn More on Nello Mainolfi's trading history.
Who are Kymera Therapeutics' active insiders?: Kymera Therapeutics' insider roster includes Bruce Booth (Director), Richard Chesworth (Insider), Jared Gollob (Insider), Bruce Jacobs (CFO), and Nello Mainolfi (CEO). Learn More on Kymera Therapeutics' active insiders.
Are insiders buying or selling shares of Kymera Therapeutics?: In the last twelve months, Kymera Therapeutics insiders bought shares 1 times. They purchased a total of 216,406 shares worth more than $2,518,965.84. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 487,346 shares worth more than $19,999,111.98. The most recent insider tranaction occured on March, 15th when Director Bruce Booth sold 71,764 shares worth more than $2,903,571.44. Insiders at Kymera Therapeutics own 16.7% of the company. Learn More about insider trades at Kymera Therapeutics.
Information on this page was last updated on 3/15/2024.

Nello Mainolfi Insider Trading History at Kymera Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/12/2022	Sell	8,612	$52.08	$448,512.96
1/10/2022	Sell	22,465	$53.26	$1,196,485.90
10/11/2021	Sell	6,456	$53.68	$346,558.08
10/8/2021	Sell	41,544	$56.76	$2,358,037.44
8/4/2021	Sell	1,037	$60.03	$62,251.11	457,868
8/2/2021	Sell	23,456	$60.30	$1,414,396.80	452,879
7/30/2021	Sell	6,279	$60.07	$377,179.53
7/28/2021	Sell	3,864	$60.15	$232,419.60	461,214
7/26/2021	Sell	9,015	$60.15	$542,252.25	461,214
7/8/2021	Sell	48,000	$49.70	$2,385,600.00	500,199
6/9/2021	Sell	5,752	$50.02	$287,715.04	424,923
6/7/2021	Sell	12,724	$50.14	$637,981.36	424,923
5/12/2021	Sell	8,245	$50.05	$412,662.25	405,444
4/26/2021	Sell	2,768	$40.18	$111,218.24	408,158
4/23/2021	Sell	680	$40.01	$27,206.80	408,158
4/19/2021	Sell	653	$40.00	$26,120.00	396,139
4/15/2021	Sell	4,940	$40.29	$199,032.60	396,139
4/12/2021	Sell	15,267	$32.62	$498,009.54	386,138
4/9/2021	Sell	22,794	$33.68	$767,701.92	386,138

Nello Mainolfi Buying and Selling Activity at Kymera Therapeutics

Kymera Therapeutics Company Overview

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $33.35

$32.75

$34.29

50 Day Range

MA: $39.02

$33.35

$43.57

2 Week Range

Now: $33.35

$9.60

$45.31

Volume

786,230 shs

Average Volume

477,940 shs

Market Capitalization

$2.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.27

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now

Nello Mainolfi Biography and Net Worth

What is Nello Mainolfi's net worth?

How old is Nello Mainolfi?

What is Nello Mainolfi's salary?

How do I contact Nello Mainolfi?

Has Nello Mainolfi been buying or selling shares of Kymera Therapeutics?

Who are Kymera Therapeutics' active insiders?

Are insiders buying or selling shares of Kymera Therapeutics?